Oral Regeneration

Leveraging our leading regenerative medicine technologies has led us to develop breakthrough applications in the field of oral soft tissue regeneration. We have completed Phase III testing of our Living Cellular Construct for oral indication and filed a Biologics License Application (BLA) application for the product with the FDA in 2011.

For additional information, please contact the Organogenesis Medical Information Center.

	Email:
	Telephone: 1-888-432-5232, Option 2